---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-235340"
form_type: "8-K"
ticker: "MDGL"
cik: "0001157601"
company_name: "MADRIGAL PHARMACEUTICALS, INC."
filed_at: "2023-09-14T23:59:59+00:00"
generated_at: "2026-06-10T17:19:51.683532+00:00"
event_type: "other"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Madrigal adopts 2023 Inducement Plan reserving 500,000 shares for new hires ahead of commercial launch

## Summary
- Board adopted Inducement Plan on Sept 8, 2023, reserving 500,000 shares of common stock for equity grants.
- Plan approved without stockholder approval per Nasdaq Listing Rule 5635(c)(4); only new employees eligible.
- Plan supports expected substantial headcount increase as company prepares for commercial launch.
- Administered by Compensation Committee; awards include options, RSUs, performance awards.

## SEC filing metadata
- accession: 0001193125-23-235340
- form_type: 8-K
- ticker: MDGL
- cik: 0001157601
- company_name: MADRIGAL PHARMACEUTICALS, INC.
- filed_at: 2023-09-14T23:59:59+00:00
- event_type: other
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1157601/000119312523235340/0001193125-23-235340-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1157601/000119312523235340/d521240d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-235340
- JSON: https://secwatch.observer/filing/0001193125-23-235340.json
- Plain text: https://secwatch.observer/filing/0001193125-23-235340.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.